Skip to content

Kodiak Sciences Inc KOD Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
Vera Therapeutics logo
Vera TherapeuticsVERA
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
Arcus Biosciences logo
Arcus BiosciencesRCUS

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's deferred tax assets and other non-current assets?
Kodiak Sciences Inc (KOD) reported deferred tax assets and other non-current assets of $8.68M in Q1 2026.
How has Kodiak Sciences Inc's deferred tax assets and other non-current assets changed year-over-year?
Kodiak Sciences Inc's deferred tax assets and other non-current assets increased by 0.2% year-over-year, from $8.66M to $8.68M.
What is the long-term trend for Kodiak Sciences Inc's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's deferred tax assets and other non-current assets has grown at a -3.2% compound annual growth rate (CAGR), from $10.21M to $8.67M.